发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 185 |
| Italy | 16 |
| Japan | 13 |
| Canada | 10 |
| Brazil | 8 |
| France | 8 |
| GERMANY (FED REP GER) | 7 |
| England | 6 |
| Switzerland | 5 |
| Belgium | 4 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| UNIVERSITY OF TEXAS SYSTEM | 25 |
| MAYO CLINIC | 14 |
| H LEE MOFFITT CANCER CENTER & RESEARCH INSTITU... | 13 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 11 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 9 |
| STATE UNIVERSITY SYSTEM OF FLORIDA | 9 |
| HARVARD UNIVERSITY | 8 |
| NORTHWESTERN UNIVERSITY | 7 |
| STANFORD UNIVERSITY | 7 |
| CLEVELAND CLINIC FOUNDATION | 6 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Current State of Immunotherapy for Treatment of Glioblas... | 45 |
| Use of Immune Checkpoint Inhibitors in Mesothelioma | 19 |
| Targeted Therapies for Triple-Negative Breast Cancer | 17 |
| Update on PARP Inhibitors in Breast Cancer | 16 |
| Epithelioid Hemangioendothelioma: Update on Diagnosis an... | 16 |
| Extranodal Diffuse Large B Cell Lymphoma: Molecular Feat... | 15 |
| Review of Immune Therapies Targeting Ovarian Cancer | 15 |
| Update on the Treatment of Early-Stage Triple-Negative B... | 15 |
| Antibody-Drug Conjugates in Breast Cancer: a Comprehensi... | 13 |
| When to Consider Immune Checkpoint Inhibitors in Oncogen... | 12 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| CANCERS | 36 |
| FRONT ONCOL | 36 |
| MEDICINE | 30 |
| INT J MOL SCI | 20 |
| BMC CANCER | 18 |
| CANCER MANAG RES | 16 |
| SCI REP-UK | 16 |
| CURR TREAT OPTION ON | 15 |
| CLIN CANCER RES | 14 |
| HEAD NECK-J SCI SPEC | 14 |